7-ANCA  Intermediate for Ceftizoxime and Ceftibuten CAS no.36923-17-8

7-ANCA Intermediate for Ceftizoxime and Ceftibuten CAS no.36923-17-8


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
Brand name
Hipharma
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
antibiotics, cephalosporin, ceftibuten, ceftizoxime
Category
Pharmaceutical Intermediates

Hipharma Limited

Country / Year Established
China China /
Business type
Others
Verified Certificate

11

Product name 7-ANCA Intermediate for Ceftizoxime and Ceftibuten CAS no.36923-17-8 Certification -
Category Pharmaceutical Intermediates Ingredients -
Keyword antibiotics , cephalosporin , ceftibuten , ceftizoxime Unit Size -
Brand name Hipharma Unit Weigh -
origin Stock -
Supply type - HS code -

Product Information

7-ANCA

Chemical Name: 7-Amino-3-cephem-4-carboxylic acid

Molecular Formula: C7H8N2O3S

Formula Weight: 200.22

CAS No.: 36923-17-8

Mp: 215-218°C

Storage temp:  -20°C Freezer

Chemical Properties: Off-White Solid

Usage: Intermediate for Ceftizoxime and Ceftibuten

Hipharma Limited is high-tech enterprise which sets R&D and production in the integration, specializing in chemical and pharmaceutical APIs and intermediates production and sales, especially in cephalosporin antibiotics field. We have the plant located in Shijiazhuang, hebei province. 

At present, we are in a position to supply the following pharmaceutical raw material and intermediates: 

1. Ceftizoxime Sodium sterile

2. Ceftizoxime Acid

3. Cefoxitin Sodium sterile

4. Cefoxitin Acid

5. Cefalotin Acid

6. Cefoperazone Sodium Sterile

7. Cefoperazone Acid

8. Cefepime Sterile with Arginine

9. Cefotiam Non sterile

10. Meropenem with Sodium Carbonate Anhydrous

11. Meropenem Non Sterile

12. Entecavir

13. 3-OH    Main chain of Cephalosporin CAS no. 54639-48-4

14. 7-ANCA  Main chain of Cephalosporin CAS no. 36923-17-8

15. 7-ADCA  Main chain of Cephalosporin  CAS no. 22252-43-3 

If you have any question to our company or products, please feel free to contact us.

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Hipharma Limited

Country / Year Established
China China /
Business type
Others

11

President
Joyce Wang
Address
Address: No. 188, Commercial Building of Xihuan Market, Kaitai Street, Qiaoxi District, Shijiazhuang, Hebei, 050081, China
Product Category
Beauty & Personal Care,Organic Intermediate,Pharmaceutical Intermediates
No. of Total Employees
1-50
Company introduction

Hipharma Limited is high-tech enterprise which sets R&D and production in the integration, specializing in chemical and pharmaceutical APIs and intermediates production and sales, especially in cephalosporin antibiotics field. We have the plant located in Shijiazhuang, hebei province. At present, we are in a position to supply the following pharmaceutical raw material and intermediates: 1. Ceftizoxime Sodium sterile 2. Ceftizoxime Acid 3. Cefoxitin Sodium sterile 4. Cefoxitin Acid 5. Cefalotin Acid 6. Cefoperazone Sodium Sterile 7. Cefoperazone Acid 8. Cefepime Sterile with Arginine 9. Cefotiam Non sterile 10. Meropenem with Sodium Carbonate Anhydrous 11. Meropenem Non Sterile 12. Entecavir 13. 3-OH Main chain of Cephalosporin CAS no. 54639-48-4 14. 7-ANCA Main chain of Cephalosporin CAS no. 36923-17-8 15. 7-ADCA Main chain of Cephalosporin CAS no. 22252-43-3 If you have any question to our company or products, please feel free to contact us.

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more